Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Strategy for Coronary Artery Reperfusion
2008-006266-29Phase 3Active
- Sponsor
- Azienda Ospedaliero-Universitaria Pisana
- Start
- Dec 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of adenosine in myocardial infarction (MI) and acute coronary syndrome (ACS) (3 arms), sponsored by Azienda Ospedaliero-Universitaria Pisana. Primary endpoint: Protective effect of adenosine on reperfusion injury. Started Dec 2008; status: active.
02
Drugs
adenosine
03
Conditions
myocardial infarction (MI)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2008-006266-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006266-29.